Lilium Teapills
En vente sur le marché américain (selon le DSLD)
Min Shan, food supplement from the US market
Lilium Teapills (Min Shan), a food supplement without a usable barcode in DSLD, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Min Shan
- Barcode
- Not provided or invalid in DSLD
- Form
- Tablet
- One serving
- « 8 Pill(s) »
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Magnesium Silicate, Hydrated, Maltose, China Wax
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Extract Blend | Blend | 1,360 mg |
| Rehmannia glutinosa Root Extract (Rehmannia glutinosa) | Plant | not stated |
| Ophiopogon japonicus Tuber Extract (Ophiopogon japonicus) | Plant | not stated |
| Lilium brownii Bulb Extract (Lilium brownii) | Plant | not stated |
| Fritillaria cirrhosa Bulb Extract | Plant | not stated |
| Angelica sinensis Root Extract (Angelica sinensis) | Plant | not stated |
| Paeonia lactiflora Root Extract (Paeonia lactiflora) | Plant | not stated |
| Glycyrrhiza uralensis Root Extract (Glycyrrhiza uralensis) | Plant | not stated |
| Scrophularia ningpoensis Root Extract | Plant | not stated |
| Platycodon grandiflorum Root Extract | Plant | not stated |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Lilium Teapills
Entered into DSLD on 22 December 2019. En vente sur le marché américain (selon le DSLD).- Active ingredient added : Angelica sinensis (quantity not stated)
- Active ingredient added : Fritillaria cirrhosa (quantity not stated)
- Active ingredient added : Glycyrrhiza uralensis (quantity not stated)
- Active ingredient added : Lilium brownii (quantity not stated)
- Active ingredient added : Ophiopogon japonicus (quantity not stated)
- Active ingredient added : Paeonia lactiflora (quantity not stated)
- Active ingredient added : Platycodon grandiflorum (quantity not stated)
- Active ingredient added : Rehmannia glutinosa (quantity not stated)
- Active ingredient added : Rehmannia glutinosa (quantity not stated)
- Active ingredient added : Scrophularia ningpoensis (quantity not stated)
- Active ingredient removed : Angelica sinensis Root Extract (quantity not stated)
- Active ingredient removed : Fritillaria cirrhosa Bulb Extract (quantity not stated)
- Active ingredient removed : Glycyrrhiza uralensis Root Extract (quantity not stated)
- Active ingredient removed : Lilium brownii Bulb Extract (quantity not stated)
- Active ingredient removed : Ophiopogon japonicus Tuber Extract (quantity not stated)
- Active ingredient removed : Paeonia lactiflora Root Extract (quantity not stated)
- Active ingredient removed : Platycodon grandiflorum Root Extract (quantity not stated)
- Active ingredient removed : Rehmannia glutinosa Root Extract (quantity not stated)
- Active ingredient removed : Rehmannia glutinosa Root Extract (quantity not stated)
- Active ingredient removed : Scrophularia ningpoensis Root Extract (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Angelica sinensis Root Extract
Read the warning, when it applies and the studies cited
DONG QUAI - ANGELICA SINENSIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid exposure to the sun (NS 2021; Thorne 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (NS 2021; WHO 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Glycyrrhiza uralensis Root Extract
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Min Shan
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.